vs
Dayforce（DAY）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是Dayforce的1.6倍（$772.1M vs $481.6M），Revvity净利率更高（12.7% vs -40.9%，领先53.6%），Dayforce同比增速更快（9.5% vs 5.9%），过去两年Dayforce的营收复合增速更高（9.8% vs 9.0%）
Dayforce前身为知名人力资源服务商Ceridian，是一家总部位于美国的人力资源软件及服务企业，面向各行业不同规模的客户提供覆盖薪酬核算、人员管理、考勤等多场景的HR SaaS产品及配套专业服务，助力企业提升人力资源运营效率。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
DAY vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.6倍
$481.6M
营收增速更快
DAY
高出3.6%
5.9%
净利率更高
RVTY
高出53.6%
-40.9%
两年增速更快
DAY
近两年复合增速
9.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $481.6M | $772.1M |
| 净利润 | $-196.8M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 6.3% | 14.5% |
| 净利率 | -40.9% | 12.7% |
| 营收同比 | 9.5% | 5.9% |
| 净利润同比 | -9940.0% | 3.9% |
| 每股收益（稀释后） | $-1.23 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DAYRVTY
| Q4 25 | — | $772.1M | ||
| Q3 25 | $481.6M | $698.9M | ||
| Q2 25 | $464.7M | $720.3M | ||
| Q1 25 | $481.8M | $664.8M | ||
| Q4 24 | $465.2M | $729.4M | ||
| Q3 24 | $440.0M | $684.0M | ||
| Q2 24 | $423.3M | $691.7M | ||
| Q1 24 | $431.5M | $649.9M |
净利润DAYRVTY
| Q4 25 | — | $98.4M | ||
| Q3 25 | $-196.8M | $46.7M | ||
| Q2 25 | $21.3M | $53.9M | ||
| Q1 25 | $14.9M | $42.2M | ||
| Q4 24 | $10.8M | $94.6M | ||
| Q3 24 | $2.0M | $94.4M | ||
| Q2 24 | $-1.8M | $55.4M | ||
| Q1 24 | $7.1M | $26.0M |
毛利率DAYRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | 47.0% | — | ||
| Q3 24 | 45.8% | 56.3% | ||
| Q2 24 | 44.1% | 55.7% | ||
| Q1 24 | 47.6% | 54.6% |
营业利润率DAYRVTY
| Q4 25 | — | 14.5% | ||
| Q3 25 | 6.3% | 11.7% | ||
| Q2 25 | 9.1% | 12.6% | ||
| Q1 25 | 6.4% | 10.9% | ||
| Q4 24 | 6.1% | 16.3% | ||
| Q3 24 | 4.7% | 14.3% | ||
| Q2 24 | 3.3% | 12.4% | ||
| Q1 24 | 9.4% | 6.8% |
净利率DAYRVTY
| Q4 25 | — | 12.7% | ||
| Q3 25 | -40.9% | 6.7% | ||
| Q2 25 | 4.6% | 7.5% | ||
| Q1 25 | 3.1% | 6.4% | ||
| Q4 24 | 2.3% | 13.0% | ||
| Q3 24 | 0.5% | 13.8% | ||
| Q2 24 | -0.4% | 8.0% | ||
| Q1 24 | 1.6% | 4.0% |
每股收益（稀释后）DAYRVTY
| Q4 25 | — | $0.86 | ||
| Q3 25 | $-1.23 | $0.40 | ||
| Q2 25 | $0.13 | $0.46 | ||
| Q1 25 | $0.09 | $0.35 | ||
| Q4 24 | $0.07 | $0.77 | ||
| Q3 24 | $0.01 | $0.77 | ||
| Q2 24 | $-0.01 | $0.45 | ||
| Q1 24 | $0.04 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $627.6M | $919.9M |
| 总债务越低越好 | $631.1M | — |
| 股东权益账面价值 | $2.7B | $7.3B |
| 总资产 | $8.7B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.23× | — |
8季度趋势，按日历期对齐
现金及短期投资DAYRVTY
| Q4 25 | — | $919.9M | ||
| Q3 25 | $627.6M | $931.4M | ||
| Q2 25 | $625.2M | $991.8M | ||
| Q1 25 | $557.3M | $1.1B | ||
| Q4 24 | $579.7M | $1.2B | ||
| Q3 24 | $494.1M | $1.2B | ||
| Q2 24 | $465.4M | $2.0B | ||
| Q1 24 | $392.5M | $1.7B |
总债务DAYRVTY
| Q4 25 | — | — | ||
| Q3 25 | $631.1M | — | ||
| Q2 25 | $631.8M | — | ||
| Q1 25 | $632.4M | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
股东权益DAYRVTY
| Q4 25 | — | $7.3B | ||
| Q3 25 | $2.7B | $7.4B | ||
| Q2 25 | $2.7B | $7.6B | ||
| Q1 25 | $2.6B | $7.6B | ||
| Q4 24 | $2.5B | $7.7B | ||
| Q3 24 | $2.6B | $7.9B | ||
| Q2 24 | $2.5B | $7.9B | ||
| Q1 24 | $2.4B | $7.8B |
总资产DAYRVTY
| Q4 25 | — | $12.2B | ||
| Q3 25 | $8.7B | $12.1B | ||
| Q2 25 | $8.5B | $12.4B | ||
| Q1 25 | $9.5B | $12.4B | ||
| Q4 24 | $9.1B | $12.4B | ||
| Q3 24 | $8.1B | $12.8B | ||
| Q2 24 | $9.0B | $13.4B | ||
| Q1 24 | $10.8B | $13.4B |
负债/权益比DAYRVTY
| Q4 25 | — | — | ||
| Q3 25 | 0.23× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.49× | — | ||
| Q1 24 | 0.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $31.2M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流DAYRVTY
| Q4 25 | — | $182.0M | ||
| Q3 25 | $31.2M | $138.5M | ||
| Q2 25 | $112.7M | $134.3M | ||
| Q1 25 | $49.6M | $128.2M | ||
| Q4 24 | $81.0M | $174.2M | ||
| Q3 24 | $91.8M | $147.9M | ||
| Q2 24 | $99.2M | $158.6M | ||
| Q1 24 | $9.1M | $147.6M |
自由现金流DAYRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | — | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | — | $129.7M |
自由现金流率DAYRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | — | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度DAYRVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率DAYRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | 5.29× | 2.49× | ||
| Q1 25 | 3.33× | 3.03× | ||
| Q4 24 | 7.50× | 1.84× | ||
| Q3 24 | 45.90× | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | 1.28× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DAY
| Dayforce Recurring | $333.0M | 69% |
| Cloud And Bureau Professional Services And Other | $78.5M | 16% |
| Float | $42.2M | 9% |
| Powerpay Recurring | $19.7M | 4% |
| Other Recurring | $8.2M | 2% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
